Supriya Lifescience Ltd. IPO
Supriya Lifescience Ltd.
IPO Listing Details
Listed On
BSE & NSE
Listed On
Issue Price
₹274
Issue Price
Listing Price
₹425
Listing Price
Listing Gains
+₹151.00 (+55.11%)
Listing Gains
IPO Details
Bidding Dates
16 Dec - 20 Dec '21
Bidding Dates
Min. Investment
₹14,310
Min. Investment
Lot Size
54.00
Lot Size
Price Range
₹265 - ₹274
Price Range
Issue Size
677 Cr
Issue Size
Subscription Rate
- Retail Individual Investor56.01x
- Non-Institutional Investor161.22x
- Qualified Institutional Buyers31.83x
- Employees
About Company
With an emphasis on research and development, Supriya LifeSciences is one of the leading Indian manufacturers and suppliers of Active Pharmaceutical Ingredients. It offers speciality offerings of 38 APIs centered on various categories such as antihistamine, analgesic, anesthetic, vitamin, anti-asthmatic, and antiallergic by the end of October 21.
They have consistently been the top exporter of Chlorpheniramine Maletas and Ketamine Hydrochloride from India, accounting for 45 to 50 percent and 60 to 65 percent of total API exports from India from 2017 to 2021, respectively.
In terms of volume, Supriya LifeSciences is the largest exporter of salbutamol sulfate in India, accounting for 31% of API exports from India in 2021. Its pharmaceutical business is divided into domestic and international sales. Its products are sold to 1,296 clients in 86 countries through 346 distributors.
Why should you invest in Supriya Lifescience Ltd. IPO?
Here are a few advantages to investing with this company.
-
The firm is one of India's most well-known API manufacturers.
-
Its products are exported to over 86 countries due to its specific and diverse market. Due to its de-risked business strategy, the company has superior research and development capabilities as well as a good financial track record.
-
In the last three years, the company has experienced strong revenue growth.
-
In the last three years, the company's margins have dramatically improved.
Financial Snapshot - Supriya LifeSciences IPO
The company’s entire assets, revenues, and profits for the last three years are represented here.
-
Details2019 (in millions)2020 (in millions)2021 (in millions)September, 2021 (in millions)
-
Total Assets2,530.53,364.04,458.25,041.0
-
Revenues2,858.63,227.13,962.22,300.6
-
PAT394.2733.71,238.3659.6
-
Profit13.79%22.74%31.25%28.67%
Important Dates - Supriya LifeSciences IPO
The following are some key dates to remember for Supriya LifeSciences' initial public offering:
-
IPO Start Date16 Dec 2021
-
IPO End Date20 Dec 2021
-
Allotment Date23 Dec 2021
-
Initiation of Refunds24 Dec 2021
-
Credit of Shares to Demat Account Date27 Dec 2021
-
IPO Listing Date28 Dec 2021
Supriya Lifescience Ltd. IPO - SWOT Analysis
Strengths:
The company has a large scale and a leadership position in the industry's main and specialty products. The firm focuses on advanced manufacturing as well as research and development. Supriya Lifescience has a professional management team with extensive expertise and trained operational people.
Weaknesses:
A complicated set of rules governs their industry. Any production or quality control problems could tarnish the reputation and expose the company to legal action or other liabilities, affecting their financial performance. The sale of specific products accounts for a significant portion of their earnings.
Opportunities:
The corporation uses an integrated business model. With a presence in around 86 countries, it is a global player.
Threats:
Their lenders have imposed some restrictions on them as part of their financial arrangements. Their inability to compete successfully in the pharmaceutical sector could hurt their firm. Existing technologies may become obsolete as a result of technological breakthroughs, necessitating major capital inputs.
A competitive analysis
A large corporation with a leadership position in important and specialized products.
It has a business model that is backward integrated.
Its revenues are geographically diverse, with a global presence in 86 countries.
Advanced manufacturing and research and development capabilities are available at the company.
Due to its de-risked business style, the company produces consistently solid financial results.
It has a senior management team with years of experience and qualified operational personnel.
How to apply for Supriya Lifescience Ltd. IPO?
You can apply for the Supriya Lifescience Ltd. IPO in these ways:
UPI
Link your personal bank A/C to a trusted UPI ID and map it with your TradeSmart account. Now, proceed further to book your IPO. On acceptance of the mandate, the bid amount will get blocked in your bank account Learn more.
Demat Account
1. If you are an Existing TradeSmart demat account holder and wish to apply for an Supriya Lifescience Ltd. click here.
2. If you don't have a TradeSmart Account? Sign up.
